The 2023 WCIRDC: Obesity.

The 21st annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, held in Los Angeles, California in December 2023, covered various aspects of diabetes, obesity, and related complications. Presentations at the conference discussed topics such as fibrosis in metabolic dysfunction-associated fatty liver disease (MAFLD), the use of body mass index (BMI) as a measure of obesity, the relationship between BMI and cardiovascular disease, calorie restriction with intermittent fasting, and the development of hormone-based therapies for obesity. The presentations highlighted the complexities and potential treatments for obesity and its associated health risks. [Extracted from the article]